Managing sebaceous adenitis and symmetrical lupoid onychodystrophy (Proceedings)

Article

A symmetrical partial alopecia and excess scaling with follicular casts. Remaining hair is dull and brittle

Sebaceous adenitis

  • Etiology

  • Unknown

  • May be an immune mediated disease

  • May be a genetically inherited defect – autosomal recessive trait.

  • Keratinization abnormality with obstruction of sebaceous duct?

  • Abnormality in sebaceous lipids?

  • Clinical features ? 2 forms

  • Sebaceous Adenitis with Hyperkeratosis – Long Coated Breeds

  • Seen in all color variants of standard poodles (may be similar in other long?coated breeds of dogs such as Samoyeds and Akitas).

  • A symmetrical partial alopecia and excess scaling with follicular casts.  Remaining hair is dull and brittle.

  • Affects dorsal planum of the nose, top of head, dorsal neck and trunk, tail and pinnae.

  • Non?pruritic and no offensive odor

  • May develop secondary bacterial folliculitis with pruritus.

  • Hair may become straight and lose its “curl”.

  • Granulomatous Sebaceous Adenitis – Short Coated Breeds

  • Affects short?coated breeds of dogs ? Vizslas, Weimaraners

  • Begins as a moth?eaten alopecia with minimal to no scaling.

  • Primarily affects the trunk, head and ears.

  • Non?pruritic

  • Diagnosis

  • Histopathology

  • Initial nodular granulomatous to pyogranulomatous inflammation at the level of the sebaceous glands.

  • Depending on the type, there may or may not be prominent hyperkeratosis.

  • Chronic cases develop a complete loss of sebaceous glands with fibrosis, atrophy of hair follicles and in some cases complete loss of the adnexa with fibrosis.

  • Treatment

  • Propylene glycol ? a hygroscopic lipid solvent that penetrates the horny layer and increases water content.  50?75% propylene glycol with water?applied daily as a spray.

  • Bath Oil Treatments (light mineral oil) – 50:50 mixture of bath oil and water, spray over the entire body, rub into the hair coat well, allow to soak for 1-2 hours. Remove oil by bathing with dish soap 2-3 times, and then finish with a moisturizing shampoo and conditioner/crème rinse for the final bathing. Repeat q 7 days for the first month, the q 14-30 days prn.

  • EFA Supplement - Derm Caps ES - 1 capsule BID; Evening Primrose Oil (EPO) - 500 mg BID.

  • Anti?seborrheic shampoos, conditioners and emollients have been of little benefit.

  • Treat secondary pyoderma if present.

  • Isotretinoin (Accutane®) - 1 mg/kg SID-BID.

  • Acetretin (Soriatane®) - 1 mg/kg SID-BID

  • Cyclosporine (Neoral, Gengraf, Atopica) - 5 mg/kg BID.

  • Vaseline Intensive Care Lotions daily without washing.

  • Allerderm Spot-On – apply daily or from 1-3 times/week prn.

  • Dermoscent Essential 6 – apply once weekly prn.

  • Douxo Calm Shampoo and Spray – apply 3 times weekly.

  • Douxo Seborrhea Shampoo and Micro-emulsion Spray – apply twice weekly.

  • Essential fatty acid dietary supplement (Derm Caps ES) – 1 capsule BID + Evening primrose oil – 500 mg BID.

  • High empirical dosages of purified fish oil daily (1000 mg?) – Marshall, Williams – Adv Vet Derm, Vol 1:446, 1990.

  • Vitamin A – 8,000-10,000 I.U. – SID-BID x 3 months, then up to 20,000-30,000 I.U. – BID.  Needs to be esterified for stability and from a quality controlled and reliable manufacturer (DSM Nutritional Products – formerly Roche; Bio-Tech Pharmaceutical). Mark Papich – 600-800 I.U./kg SID.

  • Tetracycline and Niacinamide – 10 mg/lb of each drug, not to exceed 500 mg TID of each drug.

  • Doxycycline – 5-10 mg/kg SID, with or without concurrent Niacinamide.

  • Prognosis

  • Akitas – tends to be more severe, chronic recurrent pyoderma more  of a problem, possible signs of systemic illness.

Standard Poodles – aesthetic disease, secondary pyoderma rare, difficult to regrow “normal” hair coat.

  • Short Coated Breeds – occasionally “cured” by treatment.

Lupoid onychodystrophy

  • Pathogenesis

  • Unknown

  • Suspected to be a lupus-like, immune-mediated disease

  • Secondary bacterial paronychia common (esp. Staphylococcus intermedius)

  • A possible “novel” reaction pattern to “common” underlying diseases

  • Food Allergy

  • Atopic Dermatitis

  • Clinical Features

  • German Shepherd dogs predisposed

  • Acute onset of sloughing of one or more nails

  • Nails avulse by lifting up distally from the corium, and continuing proximally to the claw fold

  • Lameness associated with avulsion of each nail

  • Subsequent loss of all nails may occur over several weeks to months

  • Regrowth characterized by short, malformed, soft, dry, brittle nails

  • Diagnosis

  • Rule out potential underlying disease processes:

  • CBC, Profile, U/A

  • ANA, Cold Agglutinins

  • Elimination diet trial testing

  • Intradermal skin testing

  • Macerated tissues culture of nail

  • Bacterial culture and sensitivity

  • Fungal culture

  • Nail biopsy techniques:

  • P3 amputation

  • Longitudinal punch biopsy (8 mm)

  • Nail trim flush to the nail fold

  • Histopathology:

  • Hydropic degeneration of basal cells

  • Lichenoid interface dermatitis

  • Treatment

  • Treat underlying disease process if possible

  • Hypoallergenic diets

  • Allergen-specific Immunotherapy (ASIT)

  • Essential fatty acid supplements - Derm Caps SID

  • Vitamin E - 400-800 IU's – BID

  • Tetracycline and Niacinamide - 10 mg/lb of each TID

  • Doxycycline – 5-10 mg/kg SID (with or without concurrent Niacinamide)

  • Biotin (Appearex®) – 2.5 mg/dog SID

  • Pentoxifylline – 15-30 mg/kg TID

  • Cyclosporine – 5 mg/kg SID

  • Systemic antibiotics based on culture and sensitivity for secondary paronychia

  • Cephalexin - 15 mg/lb BID x 2-4 months

  • Prognosis

  • Possible cure if underlying disease process is identified and treated

  • Food Allergy – lifelong hypoallergenic diets

  • Atopic Dermatitis – lifelong ASIT

  • Discontinuation of therapy invariably results in relapses

  • Regrown nails are usually malformed, soft, and friable

  • Process of avulsing nails and lameness is halted
Recent Videos
© 2024 MJH Life Sciences

All rights reserved.